Jan.13 — Merck KGaA Chief Executive Officer Stefan Oschmann says Covid vaccines based on mRNA are a “watershed moment” for the industry. He says cancer therapies based on mRNA technology could come to market in the "next few years.” He speaks on "Bloomberg Markets."